Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lova Sun

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2026
Molecular Profiling and Real-World Outcomes of BRAF V600E-Mutated Papillary Thyroid CancerMartina Chirra, Andrew Elliott, Hira Shaikh, et al.
Oral Oncology|August 19, 2024
Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic HPV-driven oropharyngeal cancerGlenn J Hanna, Jamie Jabalee, John N Lukens, et al.
The Oncologist|December 30, 2017
Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and AnalysisLova Sun, Shuli Li, Areej El-Jawahri, et al.
JNCI Cancer Spectrum|February 8, 2021
Rates of COVID-19-Related Outcomes in Cancer Compared With Noncancer PatientsLova Sun, Sanjna Surya, Anh N Le, et al.
JACC. Basic to Translational Science|February 7, 2022
Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without TrastuzumabElizabeth W Thompson, Biniyam G Demissei, Amanda M Smith, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2026
Osimertinib dose-reduction and survival in 1L EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)Adam Barsouk, Alec Heidlauf, Keshav Goel, et al.
The Oncologist|May 15, 2023
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung CancerCharu Aggarwal, Alisha P Maity, Joshua M Bauml, et al.
Lung Cancer (Amsterdam, Netherlands)|August 13, 2024
Real-world outcomes of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)treated with osimertinib (osi) vs. Afatinib or erlotinibAdam Barsouk, Omar Elghawy, Alec Heidlauf, et al.
Clinical Lung Cancer|December 6, 2020
Outcomes in Patients With Non-small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based TherapyLova Sun, Christiana W Davis, Wei-Ting Hwang, et al.
The Lancet. Haematology|March 6, 2017
Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort studyPavan K Bendapudi, Shelley Hurwitz, Ashley Fry, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2026
Molecular Profiling and Real-World Outcomes of BRAF V600E-Mutated Papillary Thyroid CancerMartina Chirra, Andrew Elliott, Hira Shaikh, et al.
Oral Oncology|August 19, 2024
Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic HPV-driven oropharyngeal cancerGlenn J Hanna, Jamie Jabalee, John N Lukens, et al.
The Oncologist|December 30, 2017
Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and AnalysisLova Sun, Shuli Li, Areej El-Jawahri, et al.
JNCI Cancer Spectrum|February 8, 2021
Rates of COVID-19-Related Outcomes in Cancer Compared With Noncancer PatientsLova Sun, Sanjna Surya, Anh N Le, et al.
JACC. Basic to Translational Science|February 7, 2022
Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without TrastuzumabElizabeth W Thompson, Biniyam G Demissei, Amanda M Smith, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2026
Osimertinib dose-reduction and survival in 1L EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)Adam Barsouk, Alec Heidlauf, Keshav Goel, et al.
The Oncologist|May 15, 2023
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung CancerCharu Aggarwal, Alisha P Maity, Joshua M Bauml, et al.
Lung Cancer (Amsterdam, Netherlands)|August 13, 2024
Real-world outcomes of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)treated with osimertinib (osi) vs. Afatinib or erlotinibAdam Barsouk, Omar Elghawy, Alec Heidlauf, et al.
Clinical Lung Cancer|December 6, 2020
Outcomes in Patients With Non-small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based TherapyLova Sun, Christiana W Davis, Wei-Ting Hwang, et al.
The Lancet. Haematology|March 6, 2017
Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort studyPavan K Bendapudi, Shelley Hurwitz, Ashley Fry, et al.
Pageof 9